Vascepa, a medication containing the active ingredient icosapent ethyl, is prescribed to manage triglyceride levels in patients at high risk of cardiovascular events [1]. For individuals with allergies, the safety of Vascepa should be carefully evaluated.
According to the Vascepa medication guide, the most common side effect reported is gastrointestinal intolerance, such as nausea, vomiting, and abdominal pain [2]. However, these symptoms are typically mild and temporary.
Regarding allergies, there is limited information available on the specific interactions between Vascepa and common allergens. Nevertheless, one notable warning is that Vascepa contains omega-3 fatty acids derived from fish oil and is therefore contraindicated in individuals with a known hypersensitivity to fish or fish products [3].
Furthermore, patients with a known allergy to fish or shellfish should only initiate Vascepa treatment under the guidance of their healthcare provider, and with strict monitoring [4]. In most instances, patients without a documented fish allergy can safely take Vascepa without incident.
Ultimately, before starting Vascepa, individuals with allergies should consult with their healthcare provider and ask about any concerns regarding the medication's potential interactions or side effects.
Sources:
[1] DrugPatentWatch.com (https://www.drugpatentwatch.com/drug/pfizer-1547/vascepa) - Vascepa (Vascepa).
[2] Pfizer. (2022). VASCEPA- icosapent ethyl injection, solution. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/204179s016lbl.pdf
[3] VASCEPA (icosapent ethyl) capsules, for oral use (https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-providers/vascepa-icosapent-ethyl-capsules-oral-use)
[4] Pfizer. (2022). VASCEPA Prescribing Information. Retrieved from https://www.vascepa.com/wp-content/uploads/2021/04/VASCEPALPI.pdf